Skip directly to searchSkip directly to A to Z list Skip directly to navigationSkip directly to site contentSkip directly to page options
CDC Home
Yellow Book Cover

Yellow Book

CDC Health Information for International Travel 2008

Chapter 4
The Post-Travel Consultation

General Approach to the Returned Traveler

Carlos Franco-Paredes

Risk of Illness in Travelers

  • An estimated 15%–70% of international travelers returning to the United States have a travel-related illness. The likelihood of developing a medical condition during travel relates to an individual’s past medical history, travel destination, duration of travel, level of accommodation, pre-travel immunization history, adherence to prescribed malaria chemoprophylaxis regimens, activities during travel, and especially to his or her history of exposure to infectious agents prior to and during travel.
  • While some illnesses that occur in returned travelers may begin during the travel period, others may occur weeks, months, or even years after return. In many cases, travelers may be harboring a pathogen in its incubation phase that becomes clinically evident in the immediate post-travel period. In terms of clinical severity, most travel-related illnesses are mild, but 1%–5% of travelers become sick enough to seek medical care either during or after travel. Thus, a history of travel, particularly within the previous 6 months, should be part of the routine medical history for every ill patient, especially those with a febrile illness.
  • Particular groups of travelers are considered at higher risk of developing illness after returning to their place of residence. Travelers visiting friends and relatives are often less likely to seek pre-travel advice, obtain vaccinations, or take antimalarial prophylaxis. Adventure travelers and persons visiting friends and relatives overseas are at greater risk for becoming ill, in part because of increased exposure to pathogens.

Types of Illnesses

  • The most frequent health problems in ill returned travelers are persistent gastrointestinal illness (10%), skin lesions or rashes (8%), respiratory infections (5%–13%, depending on season of travel), and fever (up to 3%).
  • Although gastrointestinal upset is the most frequent problem, febrile illnesses represent the most serious of the spectrum of illnesses in travelers. Infections such as malaria may be life threatening, and others may pose a serious public health hazard (e.g., tuberculosis, measles, viral hemorrhagic fever).
  • A recent analysis of the GeoSentinel Surveillance Network, a partnership of the International Society of Travel Medicine (www.istm.org) and CDC that gathers data from more than 30 travel and tropical medical clinics worldwide, has shown substantial regional differences in the morbidity of various syndromic categories in relation to place of exposure among ill returned travelers. For example, dermatologic problems were among the most frequent diagnoses among travelers returning from the Caribbean or Central or South America, while the diagnosis of acute diarrhea was more common for travelers returning from South Central Asia. Malaria was identified as one of the three most frequent causes of systemic febrile illness among travelers from any region. Other than malaria, travelers returning from sub-Saharan Africa were diagnosed most often with rickettsial infections, as well as typhoid and dengue.
  • Fever is a frequently reported complaint among returned travelers. Recently, the GeoSentinel Surveillance Network reviewed its data on 24,920 travelers. This global surveillance system reported that 28% (6,957) of returned travelers seen at GeoSentinel clinics from March 1997 through March 2006 had fever as their chief reason for seeking medical care.
  • Fever was a marker of a potentially serious illness in up to 26% of these travelers and often resulted in hospitalization. The most frequent “tropical” causes of fever in the returned traveler are malaria, dengue, invasive bacterial diarrhea, hepatitis A, typhoid, and rickettsial infections. However, nontropical entities such as respiratory or urinary tract infections account for a large proportion of febrile illnesses in returned travelers.
  • In terms of gastrointestinal illnesses, acute bacterial gastroenteritis or parasitic diarrhea caused mostly by Giardia represents the most common conditions reported by travelers. Parasitic diarrhea may often present as intermittent diarrhea, nausea, headache, and fatigue, but may also present with postprandial rapid expulsions of loose stool. Rarely, postinfectious celiac sprue or postinfectious inflammatory bowel disease may occur after travelers have been ill with travelers’ diarrhea. More frequently, causes of persistent gastrointestinal illness are postinfectious irritable bowel syndrome and postinfectious lactose intolerance after an episode of travelers’ diarrhea.
  • Although infections such as giardiasis or cyclosporiasis are often treated on the basis of clinical findings (without the benefit of laboratory confirmation), intestinal parasitic infections are uncommon causes of persistent diarrhea.
  • Most post-travel skin ailments reported are insect bites, pyoderma, scabies, and cutaneous larva migrans.
  • A number of diseases may occur months to years after return. The risk is related to the degree of exposure, the duration and season of travel, and the underlying health of the traveler. Some of these late-appearing illnesses include chronic forms of Chagas disease, cutaneous and mucocutaneous leishmaniasis, chronic forms of brucellosis, reactivation of tuberculosis from travel-acquired latent tuberculosis infection, malaria, sequelae of schistosomiasis, and reactivation of chronic systemic mycoses, such as paracoccidioidomycosis or coccidioidomycosis.

Clinical Presentations

  • Most travelers infected abroad become ill within 12 weeks after returning to the United States. However, some diseases, such as malaria, may not cause symptoms for as long as 6–12 months or more after exposure (Table 4-1).
  • If travelers become ill after they return home, even many months after travel, they should be advised to tell their physician where they have traveled. In particular, fever in a traveler returned from a malarious area should be considered a medical emergency.
  • The possibility of malaria as a cause of the fever should be evaluated urgently by appropriate laboratory tests and qualified personnel, and testing should be repeated if the initial result is negative. In this regard, primary care physicians, general medicine practitioners, pediatricians, emergency medicine physicians, and every health-care worker dealing with a febrile returned traveler from a malaria-endemic area should take steps to ensure the patient has serial blood smears evaluated on the day of presentation and consider hospitalization if there is any need for observation.
  • In evaluating patients seeking medical care, it is essential to obtain a detailed history of exposures, such as insect bites; swimming in freshwater; animal bites; sexual contacts; and eating raw meat, seafood, or unpasteurized dairy products.
  • Answers to these questions may provide important clues for diagnosis of a particular illness or syndrome in returned travelers. In addition, when an infectious disease is suspected, calculating an approximate incubation period is a useful step in ruling out possible etiologies. For example, fever beginning 3 weeks or longer after return greatly reduces the probability of dengue, rickettsial infections, and viral hemorrhagic fevers in the differential diagnosis.
  • This important step helps focus the differential diagnosis on probable causative agents and eliminates unlikely considerations. As indicated by exposure history, time course of illness, and associated signs and symptoms, initial investigations for febrile travelers may include prompt evaluation of peripheral blood for Plasmodium species; a complete blood cell count with differential; liver enzymes; urinalysis; culture of blood, stool, and urine; and chest radiography. More specific diagnostic assays may be useful initially for diseases such as leptospirosis (serology) and acute HIV infection (RNA viral load). However, sometimes acute- and convalescent-phase serologies are required to confirm a particular diagnosis, such as many rickettsial infections.
  • Since most primary care physicians have little expertise in tropical diseases, a newly returned, ill international traveler should be preferentially evaluated by an infectious disease or tropical medicine practitioner. For assistance in finding a provider who practices clinical tropical medicine, access the American Society of Tropical Medicine and Hygiene website for a listing by state at www.astmh.org or the International Society of Travel Medicine at www.istm.org.

Table 4-01. Incubation periods of frequent febrile syndromes in returned travelers

Incubation Period SyndromesEtiologies
< 2 weeksFever with initial nonspecific signs and symptomsMalaria, dengue, scrub typhus, spotted group rickettsiae, acute HIV, acute hepatitis C, Campylobacter, salmonellosis, shigellosis, African trypanosomiasis, leptospirosis, relapsing fever
Fever and coagulopathy Meningococcemia, leptospirosis and other bacterial pathogens associated with coagulopathy, malaria, viral hemorrhagic fevers
Fever and central
nervous system
involvement
Malaria, typhoid fever, rickettsial typhus (epidemic caused by Rickettsia prowazecki), meningococcal meningitis, rabies, arboviral encephalitis, African trypanosomiasis, encephalitis or meningitis due to worldwide distributed known pathogens, angiostrongyloidiasis, rabies
Fever and pulmonary involvement Influenza, pneumonia due to typical pathogens, Legionella pneumonia, acute histoplasmosis, acute coccidioidomycosis, Q fever, SARS, malaria
Fever and skin rash Viral exanthems (rubella, varicella, mumps, herpes simplex-6), dengue, spotted or typhus group rickettsiosis, typhoid fever, parvovirus B19
2–6 weeksVarious syndromes (fever with pulmonary, dermatologic, central nervous system, or involvement of other sites)Malaria, tuberculosis, hepatitis A, hepatitis B, hepatitis E, visceral leishmaniasis, acute schistosomiasis, amebic liver abscess, leptospirosis, African trypanosomiasis, viral hemorrhagic fevers, Q fever, acute American trypanosomiasis (Chagas disease)
> 6 weeksVarious syndromes (fever with pulmonary, dermatologic, central nervous system, or involvement of other sites)Malaria, tuberculosis, hepatitis B, hepatitis E, visceral leishmaniasis, filariasis, onchocerciasis, schistosomiasis, amebic liver abscess, chronic mycoses, African trypanosomiasis, rabies, typhoid fever

References

  1. Hill DR. Health problems in a large cohort of Americans traveling to developing countries.   J Travel Med. 2000;7(5):259–66.
  2. Hill DR. The burden of illness in international travelers. N Engl J Med. 2006;354(2):115–7.
  3. Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med. 2002;347(7):505–16.
  4. O’Brien D, Tobin S, Brown GV, Torresi J. Fever in returned travelers: review of hospital admissions for a 3-year period. Clin Infect Dis. 2001;33(5):603–9.
  5. Franco-Paredes C, Keystone J. Fever in the returned traveler. Antimicrobial Therapy and Vaccines. Empiric Section. [cited 2008 Jun 1]. Available from: http://www.antimicrobe.org.
  6. Wilson ME, Weld LH, Boggild A, et al. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis. 2007;44(12):1560–8.
  7. Freedman DO, Weld LH, Kozarsky PE, et al; GeoSentinel Surveillance Network. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354(2):119–30.
  8. Steffen R, Rickenbach M, Wilhelm U, et al. Health problems after travel to developing countries. J Infect Dis. 1987;156(1):84–91.
  9. Angell SY, Behrens RH. Risk assessment and disease prevention in travelers visiting friends and relatives. Infect Dis Clin North Am. 2005;19(1):49–65.
  10. Bacaner N, Stauffer B, Boulware DR, et al. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA. 2004;291(23):2856–64.
  11. Leder K, Tong S, Weld L, et al.; GeoSentinel Surveillance Network. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2006;43(9):1185–93.
  12. Mutsch MM, Spicher VM, Gut C, Steffen R. Hepatitis A virus infections in travelers, 1988–2004. Clin Infect Dis. 2006;42(4):490–7.
  13. Jensenius M, Fournier PE, Raoult D. Rickettsioses and the international traveler. Clin Infect Dis. 2004;39(10):1493–9.
  14. Basnyat B, Maskey AP, Zimmerman MD, Murdoch DR. Enteric (typhoid) fever in travelers. Clin Infect Dis. 2005;41(10):1467–72.
  15. Freedman DO, Leder K. Influenza: changing approaches to prevention and treatment in travelers. J Travel Med. 2005;12(1):36–44.
  16. Mutsch M, Tavernini M, Marx A, et al. Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis. 2005;40(9):1282–7.
  17. Leder K, Sundararajan V, Weld L, et al.; GeoSentinel Surveillance Group. Respiratory tract infections in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis. 2003;36(4):399–406.
  18. Connor BA. Sequelae of traveler’s diarrhea: focus on postinfectious irritable bowel syndrome. Clin Infect Dis. 2005;41(Suppl 8):S577–86.
  19. Wilson ME, Chen LH. Dermatologic infectious diseases in international travelers. Curr Infect Dis Rep. 2004;6(1):54–62.
  20. Schwartz E, Kozarsky P, Wilson M, Cetron M. Schistosome infection among river rafters     on Omo River, Ethiopia. J Travel Med. 2005;12(1):3–8.
  • Page last reviewed: July 27, 2009
  • Page last updated: July 27, 2009
  • Page created: July 27, 2009
  • Content source:
    Division of Global Migration and Quarantine
    National Center for Preparedness, Detection, and Control of Infectious Diseases
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    24 Hours/Every Day
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov